One Gut Bacterium Nearly Doubles Anxiety Risk in 1,000-Person Study

If you have ever wondered whether your gut is quietly making your anxiety worse, a new clinical study offers some of the most concrete evidence yet that it might be. Researchers who profiled the gut bacteria of 1,000 adults found that people with clinically significant anxiety carried a distinctly different microbial signature than those without it, and the difference held up even after accounting for other health and lifestyle factors. The findings will not tell you what to do about your own anxiety, but they add real weight to the idea that the gut-brain connection is more than wellness-industry marketing.

Key takeaways:

• People with clinically significant anxiety had lower levels of Bifidobacterium longum and higher levels of Clostridium difficile than people without anxiety, in a study of 1,000 adults.
• The link held even after researchers statistically adjusted for other health and environmental factors, and people who had used antibiotics had 1.8 times higher odds of anxiety.
• The study is observational, so it cannot prove gut bacteria cause anxiety, only that the two are statistically connected.
• Larger, longer-running studies are needed before gut-microbiome testing or probiotic treatment could be considered a reliable anxiety intervention.

Gut Bacteria Dysbiosis Linked to Anxiety Severity

A large multicenter study published in the Middle East Research Journal of Microbiology and Biotechnology found that adults with clinically significant anxiety carry a distinct pattern of gut bacteria imbalance (dysbiosis, an unhealthy shift in the mix of microbes living in the gut) compared with adults without anxiety, and that pattern predicts anxiety severity independently of other factors. Two species stood out. Anxiety severity was positively correlated with levels of Clostridium difficile (a bacterium best known for causing intestinal infections, but here measured simply as part of the normal gut community) at r = 0.30, with an adjusted odds ratio of 1.9, meaning higher C. difficile abundance was associated with nearly double the odds of clinically significant anxiety. Anxiety severity was negatively correlated with Bifidobacterium longum, a bacterium generally considered beneficial, at r = -0.25, with an adjusted odds ratio of 0.6. At the broader group level, people with anxiety also showed significantly less Bifidobacterium and significantly more Clostridium species overall (p<0.001).

Anxiety Patients and the Gut-Brain Axis Stakes

Anyone managing an anxiety disorder, or a gut condition like IBS or IBD that frequently travels alongside anxiety, has a stake in this finding because it strengthens the case that the gut and the brain are mechanistically linked, not just anecdotally connected. The gut-brain axis (the two-way communication network between gut microbes and the central nervous system, running through nerve signaling, immune activity, and microbial byproducts) has been an active area of psychiatric research, and this study is among the largest to test it in a clinical anxiety population rather than a small research cohort. A broader review of the gut microbiome's role in anxiety disorders describes similar depletions of beneficial bacteria and increases in pro-inflammatory taxa across multiple smaller studies, which is consistent with what this larger sample found. The study's authors also flagged antibiotic use as an independent risk factor for anxiety, adding to a growing body of evidence, including a review connecting antibiotic-driven gut disruption to depression risk, that disrupting gut bacteria with medication can have knock-on effects for mood and mental health.

Inside the 1,000-Person Multicenter Microbiome Study

Researchers recruited 1,000 adults aged 18 to 65 across multiple clinical and hospital sites, split into 300 people with clinically significant anxiety, measured using the Hamilton Anxiety Rating Scale (a standardized, clinician-administered anxiety severity test), and 700 controls without it. People with chronic inflammatory conditions, immunosuppressive treatment, or severe psychiatric conditions were excluded. Everyone provided a stool sample for 16S rRNA sequencing (a DNA-based lab method that identifies which bacterial species are present in a sample), run on an Illumina MiSeq platform and classified against the SILVA reference database, plus blood samples to measure inflammatory markers like C-reactive protein and iron levels. Researchers then used multivariable logistic regression, a statistical method that isolates the independent effect of one factor while holding others constant, to check whether the gut bacteria differences held up after adjusting for age, sex, smoking, iron levels, inflammation, and antibiotic use. They did.

What Gut Dysbiosis Findings Mean for You

For a reader trying to translate this into something useful, the honest answer is: not much, yet, beyond context. The study's own authors stopped well short of recommending a specific probiotic or diet, noting only that microbiota-targeted interventions such as probiotics and dietary changes are a "promising" avenue worth studying further, a view echoed in a broader review of microbiota-targeted approaches to anxiety and depression, not a proven treatment. That caution matters because Bifidobacterium longum specifically has shown mixed results in trials; one exploratory clinical trial found B. longum supplementation reduced perceived psychological stress in healthy adults, while other small trials have shown no effect. If you are managing anxiety and also dealing with a gut condition, this study is a reasonable thing to mention to a doctor as background, but it is not evidence that a supplement, probiotic, or elimination diet will change your anxiety symptoms.

Key Limitations: Correlation, Not Causation

The biggest limitation of this study is built into its design: because it is cross-sectional and observational (it captured a single snapshot of each participant rather than tracking anyone over time), it cannot determine whether gut dysbiosis causes anxiety, whether anxiety changes gut bacteria through stress hormones or diet, or whether some third factor drives both. The microbiome analysis was also limited to 16S rRNA sequencing, which identifies which bacteria are present but does not reveal what those bacteria are actually doing metabolically; the study's authors call this out directly and recommend future metagenomic and metabolomic work to fill that gap. It is also worth noting this is a single study, not yet independently replicated, published in a smaller specialty journal rather than a large general-medicine outlet.

What Comes Next: Longitudinal and Mechanistic Studies

The study's own authors call for prospective longitudinal studies, ones that track the same people's gut bacteria and anxiety scores over months or years, to establish whether the relationship is causal rather than simply correlated. They also point to a need for the kind of metagenomic and metabolomic follow-up that could explain what these bacteria are producing that might influence mood. On the treatment side, researchers reviewing the broader field continue to call for larger randomized controlled trials of probiotics in people who actually have diagnosed anxiety, rather than healthy volunteers, before microbiota-targeted therapy could be considered a real clinical option.

Common Questions

Can changing my gut bacteria actually reduce my anxiety?

Not based on this study alone. It found a statistical association, not proof that adjusting your microbiome would change your anxiety, and the researchers explicitly call for future trials before that conclusion could be drawn.

Should I avoid antibiotics because of this study?

No. The study only found an association between antibiotic use and higher anxiety odds; antibiotics remain necessary and appropriate for treating bacterial infections, and this finding is not a reason to skip a doctor-prescribed course.

What is 16S rRNA sequencing?

It is a lab method that identifies which bacterial species are present in a sample, such as stool, by reading a gene segment shared across bacteria. It does not show what those bacteria are actively producing or doing, which requires separate metagenomic or metabolomic testing.

Is Clostridium difficile in this study the same as a C. diff infection?

No. The study measured the relative abundance of Clostridium difficile within the gut microbiome using sequencing, not a clinical C. diff infection diagnosis, so the result describes a shift in bacterial population levels rather than an active infection.

References

1. Mohammed Mudhafar Alkhuzaie, Ahmed Sami Salman, Shahad Ali Mahdi (2026). Gut Microbiota Dysbiosis as an Independent Predictor of Anxiety Severity: A Large Multicenter Clinical Study. Middle East Research Journal Microbiology and Biotechnology. https://doi.org/10.36348/merjmb.2026.v06i02.007
2. A review of antibiotics, depression, and the gut microbiome. sciencedirect.com. https://www.sciencedirect.com/science/article/abs/pii/S0165178119303701
3. Marcus Boehme, Noëla Rémond-Derbez, Clara Lerond, et al. (2023). Bifidobacterium longum subsp. longum Reduces Perceived Psychological Stress in Healthy Adults: An Exploratory Clinical Trial. Nutrients. https://doi.org/10.3390/nu15143122